Mira has a M.Sc in Molecular Bioscience and Immunology and joined the Diatec team in 2018. After 3 years as Key Account Manager she moved on to fill the position as Site Manager at our Diagnostics production site. When the company was aquired by Curida Biologics in 2022, Curida Diatec reorganized and Mira was asked to temporary lead operations at the two manufacturing sites in addition to business development. In May 2024 Mira was promoted to Director of Curida Diatec. Mira has a background from Basal Medical Research at Oslo University Hospital and a broad experience in sales and customer service from other industries.
Menu
The trusted partner. For better lives.
